Literature DB >> 30489625

Self-Formation of RPE Spheroids Facilitates Enrichment and Expansion of hiPSC-Derived RPE Generated on Retinal Organoid Induction Platform.

Shengxu Liu1, Bingbing Xie1, Xiaojing Song1, Dandan Zheng1, Liwen He1, Guilan Li1, Guanjie Gao1, Fuhua Peng2, Minzhong Yu1,3, Jian Ge1, Xiufeng Zhong1.   

Abstract

Purpose: Retinal pigment epithelium (RPE) and neural retina could be generated concurrently through retinal organoid induction approaches using human induced pluripotent stem cells (hiPSCs), providing valuable sources for cell therapy of retinal degenerations. This study aims to enrich and expand hiPSC-RPE acquired with this platform and explore characteristics of serially passaged RPE cells.
Methods: RPE has been differentiated from hiPSCs with a published retinal organoid induction method. After detachment of neural retina on the 4th week, the remaining mixture was scraped from the dish and subjected to suspension culture for the formation of RPE spheroids. RPE sheets were isolated and digested for expansion. The cellular, molecular, and functional features of expanded RPE cells were evaluated by different assays.
Results: Under suspension culture, hiPSC-RPE spheroids with pigmentation self-formed were readily enriched by removing the non-retinal tissues. RPE sheets were further dissected and purified from the spheroids. The individualized RPE cells could be passaged every week for at least 5 times in serum medium, yielding large numbers of cells with high quality in a short period. In addition, when switched to a serum-free medium, the passaged RPE cells could mature in cellular, molecular, and physiological levels, including repigmentation, markers expression, and phagocytosis. Conclusions: We developed a simple and novel RPE spheroids formation approach to enrich and expand hiPSC-RPE cells generated along with retinal neurons on a universal retinal organoid induction platform. This achievement will reduce the cost and time in producing retinal cells for basic and translational researches, in particular for retinal cell therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30489625     DOI: 10.1167/iovs.17-23613

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and Müller Glia Are Targets of AAV5.

Authors:  Peter M Quinn; Thilo M Buck; Aat A Mulder; Charlotte Ohonin; C Henrique Alves; Rogier M Vos; Monika Bialecka; Tessa van Herwaarden; Elon H C van Dijk; Mays Talib; Christian Freund; Harald M M Mikkers; Rob C Hoeben; Marie-José Goumans; Camiel J F Boon; Abraham J Koster; Susana M Chuva de Sousa Lopes; Carolina R Jost; Jan Wijnholds
Journal:  Stem Cell Reports       Date:  2019-04-04       Impact factor: 7.765

2.  Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber's Congenital Amaurosis Patient With Novel RPE65 Mutations.

Authors:  Guilan Li; Guanjie Gao; Panfeng Wang; Xiaojing Song; Ping Xu; Bingbing Xie; Tiancheng Zhou; Guangjin Pan; Fuhua Peng; Qingjiong Zhang; Jian Ge; Xiufeng Zhong
Journal:  Front Mol Neurosci       Date:  2019-09-11       Impact factor: 5.639

3.  Multiocular organoids from human induced pluripotent stem cells displayed retinal, corneal, and retinal pigment epithelium lineages.

Authors:  Helena Isla-Magrané; Anna Veiga; José García-Arumí; Anna Duarri
Journal:  Stem Cell Res Ther       Date:  2021-11-22       Impact factor: 6.832

4.  Histologic Cell Shape Descriptors for the Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Comparison to Unaffected Eyes.

Authors:  Leon von der Emde; Marc Vaisband; Jan Hasenauer; Leonie Bourauel; Katharina Bermond; Marlene Saßmannshausen; Rainer Heintzmann; Frank G Holz; Christine A Curcio; Kenneth R Sloan; Thomas Ach
Journal:  Transl Vis Sci Technol       Date:  2022-08-01       Impact factor: 3.048

5.  Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation.

Authors:  Yuqin Liang; Feng Tan; Xihao Sun; Zekai Cui; Jianing Gu; Shengru Mao; Hon Fai Chan; Shibo Tang; Jiansu Chen
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

6.  A simple and efficient method for generating human retinal organoids.

Authors:  Florian Regent; Holly Y Chen; Ryan A Kelley; Zepeng Qu; Anand Swaroop; Tiansen Li
Journal:  Mol Vis       Date:  2020-03-03       Impact factor: 2.367

7.  Establishment of a Rapid Lesion-Controllable Retinal Degeneration Monkey Model for Preclinical Stem Cell Therapy.

Authors:  Guanjie Gao; Liwen He; Shengxu Liu; Dandan Zheng; Xiaojing Song; Wenxin Zhang; Minzhong Yu; Guangwei Luo; Xiufeng Zhong
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.